Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Blog
Supplements
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Blog
Supplements
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
More articles from ABSTRACTS OF THE EIGHTH EDCTP FORUM, 6–9 NOVEMBER 2016
Email alerts
More articles from ABSTRACTS OF THE EIGHTH EDCTP FORUM, 6–9 NOVEMBER 2016
EFFICACY AND SAFETY OF ARTEMISININ-BASED COMBINATION THERAPIES IN PEOPLE WITH
PLASMODIUM FALCIPARUM
MALARIA RECEIVING ANTIRETROVIRAL THERAPY IN ZAMBIA
Mike
Chaponda
BMJ Global Health
Feb 2017,
2
(Suppl 2)
A20;
DOI:
10.1136/bmjgh-2016-000260.49
FEASIBILITY OF IMPLEMENTING A CONTINUOUS HOUSEHOLD MALARIA INDICATOR SURVEY IN RARIEDA SUB-COUNTY, SIAYA COUNTY, WESTERN KENYA
Brian
Seda
,
Titus
Kwambai
,
Phelix
Jangu
,
Aaron
Samuels
,
Feike ter
Kuile
,
Simon
Kariuki
BMJ Global Health
Feb 2017,
2
(Suppl 2)
A28;
DOI:
10.1136/bmjgh-2016-000260.71
CULTIVATION OF TWO IS2404 POSITIVE
MYCOBACTERIUM SPP.
FROM THE ENVIRONMENT OF ASANTE AKIM DISTRICT OF GHANA
Innocent
Afeke
,
Phyllis
Addo
,
Mercy
Newman
,
Lies
Durnez
,
Miriam
Eddyani
,
Nana
Ammisah
,
Mona
Abas
,
Maxwell
Quartey
,
Anthony
Ablordey
BMJ Global Health
Feb 2017,
2
(Suppl 2)
A58-A59;
DOI:
10.1136/bmjgh-2016-000260.156
PREVALENCE AND CLINICAL SIGNIFICANCE OF SCHISTOSOMIASIS-CHRONIC HEPATITIS B VIRUS CO-INFECTION IN ZAMBIA
Caroline
Chisenga
,
Edford
Sinkala
,
Roma
Chilengi
,
Hellen
Chitundu
,
Zude
Zyambo
,
Gilles
Wandeler
,
Michael
Vinikoor
BMJ Global Health
Feb 2017,
2
(Suppl 2)
A8-A9;
DOI:
10.1136/bmjgh-2016-000260.18
MALARIA
Abdisalan
Noor
BMJ Global Health
Feb 2017,
2
(Suppl 2)
A4;
DOI:
10.1136/bmjgh-2016-000260.6
PATTERNS OF MOLECULAR MARKERS OF RESISTANCE IN ‘REAL LIFE’ REPETITIVE DIHYDROARTEMISININ-PIPERAQUINE MALARIA TREATMENT: A MOLECULAR ANALYSIS OF THE WANECAM CLINICAL TRIAL PLATFORM OUTPUT
Aminatou
Kone
,
Issaka
Sagara
,
Anders
Björkman
,
Abdoulaye
Djimde
,
Jose Pedro
Gil
BMJ Global Health
Feb 2017,
2
(Suppl 2)
A15;
DOI:
10.1136/bmjgh-2016-000260.35
NEW POSSIBILITIES FOR THE DEVELOPMENT OF A COMBINED VACCINE AGAINST ETEC AND
SHIGELLA
Richard
Walker
BMJ Global Health
Feb 2017,
2
(Suppl 2)
A11-A12;
DOI:
10.1136/bmjgh-2016-000260.26
EVIDENCE OF
PLASMODIUM FALCIPARUM
RESISTANCE TO SULPHADOXINE-PYRIMETHAMINE (SP) IN PREGNANT WOMEN ALONG THE SLOPE OF MOUNT CAMEROON
Lenshina
Agbor
,
Tobias
Apinjoh
BMJ Global Health
Feb 2017,
2
(Suppl 2)
A17;
DOI:
10.1136/bmjgh-2016-000260.41
DIAGNOSTIC TOOLS FOR HUMAN AFRICAN TRYPANOSOMIASIS ELIMINATION AND CLINICAL TRIALS: THE DITECT-HAT PROJECT
Veerle
Lejon
,
Hamidou
Ilboudo
,
Dieudonné
Mumba
,
Mamady
Camara
,
Dramane
Kaba
,
Crispin
Lumbala
,
Eric
Fèvre
,
Vincent
Jamonneau
,
Bruno
Bucheton
,
Philippe
Büscher
BMJ Global Health
Feb 2017,
2
(Suppl 2)
A8;
DOI:
10.1136/bmjgh-2016-000260.17
IMPROVING MATERNAL AND CHILD HEALTH THROUGH COMMUNITY ENGAGEMENT IN CLINICAL TRIALS
Khátia
Munguambe
BMJ Global Health
Feb 2017,
2
(Suppl 2)
A5;
DOI:
10.1136/bmjgh-2016-000260.9